Ricardo Escarcena

Ricardo Escarcena

Auto-generated profile, based on publicly available information

Ricardo Escarcena

Departamento de Química Farmacéutica, Facultad de Farmacia, CIETUS, IBSAL, Universidad de Salamanca, Salamanca, Spain

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 1995 in Tetrahedron
Verified
Journal Article
Closed access
JUJulio G. Urones
Julio G. Urones
David DiezDavid Diez
David Diez
IMIsidro S. Marcos
Isidro S. Marcos
PBPilar Basabe
Pilar Basabe
ALAnna M. Lithgow
Anna M. Lithgow
RERicardo Escarcena
Ricardo Escarcena

1 October 2009 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
EOEsther Del Olmo
Esther Del Olmo
Gloria Molina SalinasGloria Molina Salinas
Gloria Molina Salinas
RERicardo Escarcena
Ricardo Escarcena
MAMario Alves
Mario Alves
JLJosé Luis López-Pérez
José Luis López-Pérez
AFArturo San Feliciano
Arturo San Feliciano

1 September 2010 in Pharmacological Reports
Verified
Journal Article
Closed access
FBFátima de Campos Buzzi
Fátima de Campos Buzzi
MFMauricio Fracasso
Mauricio Fracasso
VFValdir Cechinel Filho
Valdir Cechinel Filho
RERicardo Escarcena
Ricardo Escarcena
EOEsther Del Olmo
Esther Del Olmo
AFArturo San Feliciano
Arturo San Feliciano

20 June 2008 in Phytomedicine
Verified
Journal Article
Closed access
LBLuis Miguel Bedoya
Luis Miguel Bedoya
AÁAmparo Álvarez
Amparo Álvarez
MBMercedes Bermejo
Mercedes Bermejo
NGNuria González
Nuria González
MBManuela Beltrán
Manuela Beltrán
JAJosé Alcami
José Alcami

28 June 2016 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
ALAna L. Legarda-Ceballos
Ana L. Legarda-Ceballos
JLJulio López-Abán
Julio López-Abán
EOEsther Del Olmo
Esther Del Olmo
RERicardo Escarcena
Ricardo Escarcena
LBLuis Bustos
Luis Bustos
AMAntonio Muro
Antonio Muro
Strongyloidiasis is a parasitic disease widely present in tropical and subtropical areas. Strongyloides stercoralis represents the main species that infects human beings. Ivermectin is the current drug of choice; however, issues related with treatment failure in patients with diabetes or infected with T-lymphotropic virus-1 make the identification of new molecules for alternative treatment a priority. In the present study, the activity of sphingosine-related aminoalcohol and diamine were evaluated against Strongyloides venezuelensis third-stage larva (L3) cultures and experimental infections in mice. The efficacy of each compound against L3 was assessed using both XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) assay and microscopic observation with concentrations ranging from 1 to 350 μM. Cytotoxicity was evaluated using J774.2 macrophage cell line and XTT assay. Lethal concentration 50 (LC50), selectivity index (SI) and structure-activity relationships were established. The activity compounds 4 (2-(ethylamino) hexadecan-1-ol), 6 (2-(butylamino) hexadecan-1-ol), 17 (tert-butyl N-(1-aminododecan-2-yl) carbamate) and 18 (tert-butyl N-(1-aminohexadecan-2-yl) carbamate) were further assessed against experimental S. venezuelensis infections in CD1 mice measuring reductions in the numbers of parthenogenetic females and egg passed in faeces. Mice were infected with 3,000 L3 and treated with 20 mg/kg/day for five days. In the screening study of 15 aminoalcohols [lauryl (n = 9); palmityl (n = 13); stearyl (n = 15) and alcohol derivatives], the presence of a palmitol chain was associated with the highest efficacy against L3 (LC50 31.9–39.1 μM). Alkylation of the 2-amino group with medium size fragments as ethyl or n-butyl showed the best larvicidal activity. The dialkylation did not improve efficacy. Aminoalcohols 4 and 6 showed the highest SI (1.5 and 1.6, respectively). With respect to diamine derivative compounds, a chain size of sixteen carbon atoms (palmitoyl chain, n = 13), and the alkylation of the 2-amino group with medium-sized fragments, were associated with the highest lethal activities. The presence of carbamoyl group in diamines 17 and 18 yielded high SI (1.7 and 1.4, respectively). Infected mice treated with aminoalcohol 6 showed reduction in parthenogenetic females (59 %) and eggs in faeces (51 %). These results support the potentiality of aminoalcohol and diamine sphingosine-related compounds as suitable prototypes for developing new promising drugs against strongyloidiasis.

21 April 2015 in Molecules
Verified
Journal Article
Open access
PDF file
RERicardo Escarcena
Ricardo Escarcena
JPJonathan Perez-Meseguer
Jonathan Perez-Meseguer
EOEsther Del Olmo
Esther Del Olmo
BABlanca Alanis-Garza
Blanca Alanis-Garza
Elvira Garza-GonzálezElvira Garza-González
Elvira Garza-González
NWNoemi Waksman
Noemi Waksman
Seventeen new derivatives of the natural diterpene leubethanol, including some potential pro-drugs, with changes in the functionality of the aliphatic chain or modifications of aromatic ring and the phenolic group, were synthesized and tested in vitro by the MABA technique for their activity against the H37Rv strain of Mycobacterium tuberculosis. Some compounds showed antimycobacterial selectivity indices higher than leubethanol.